|
Volumn 372, Issue 8, 2014, Pages 775-776
|
HPV "Coverage"
|
Author keywords
[No Author keywords available]
|
Indexed keywords
WART VIRUS VACCINE;
COST BENEFIT ANALYSIS;
DISEASE ASSOCIATION;
DRUG EFFICACY;
EDITORIAL;
HEALTH INSURANCE;
HUMAN;
IMMUNOGENICITY;
INFECTION PREVENTION;
NONHUMAN;
PAPILLOMAVIRUS INFECTION;
PRECANCER;
PRIMARY MEDICAL CARE;
UTERINE CERVIX CANCER;
VACCINATION;
WART VIRUS;
ALPHAPAPILLOMAVIRUS;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
FEMALE;
PAPILLOMAVIRUS INFECTIONS;
UTERINE CERVICAL NEOPLASMS;
ALPHAPAPILLOMAVIRUS;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
FEMALE;
HUMANS;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
UTERINE CERVICAL NEOPLASMS;
|
EID: 84923066591
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe1415742 Document Type: Editorial |
Times cited : (22)
|
References (8)
|